Definium Therapeutics, Inc. (DFTX)
38.81
+0.13
(+0.34%)
USD |
NASDAQ |
Sep 18, 16:00
39.00
+0.19
(+0.49%)
After-Hours: 05:16
Definium Therapeutics Total Long Term Debt (Quarterly) : 36.47M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 36.47M |
| March 31, 2026 | 40.77M |
| December 31, 2025 | 40.58M |
| September 30, 2025 | 40.38M |
| June 30, 2025 | 41.19M |
| March 31, 2025 | 22.04M |
| December 31, 2024 | 21.85M |
| September 30, 2024 | 24.31M |
| June 30, 2024 | 24.25M |
| March 31, 2024 | 14.19M |
| December 31, 2023 | 14.13M |
| September 30, 2023 | 14.07M |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| August 31, 2019 | 0.00 |
| May 31, 2019 | 0.00 |
| February 28, 2019 | 0.00 |
| November 30, 2018 | 0.00 |
| August 31, 2018 | 0.00 |
| May 31, 2018 | 0.00 |
| February 28, 2018 | 0.00 |
| November 30, 2017 | 0.00 |
| August 31, 2017 | 0.00 |
| May 31, 2017 | 0.00 |
| February 28, 2017 | 0.00 |
| November 30, 2016 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Enliven Therapeutics, Inc. | 0.913M |
| Cocrystal Pharma, Inc. | 0.989M |
| CNBX Pharmaceuticals, Inc. | 0.00 |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 6.30M |